Use of quantitative hepatitis B surface antigen with hepatitis B virus DNA in clinical practice

Authors

  • Grace Lai-Hung Wong,

    1. Institute of Digestive Disease and the Chinese University of Hong Kong, Hong Kong SAR, China
    2. Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong SAR, China
    Search for more papers by this author
  • Henry Lik-Yuen Chan

    Corresponding author
    1. Institute of Digestive Disease and the Chinese University of Hong Kong, Hong Kong SAR, China
    2. Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong SAR, China
    • Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, 30-32 Ngan Shing Street, Shatin, Hong Kong
    Search for more papers by this author

  • Potential conflict of interest: Grace L.-H. Wong has served as an advisory committee member for Otsuka, and a speaker for Echosens. Henry L.-Y. Chan is a consultant for Abbott, Bristol-Myer Squibb, Gilead, Merck, Novartis, and Roche; has received lecture honoraria from Abbott, Bristol-Myers Squibb, Echosens, Gilead, Glaxo-Smith-Kline, Merck, Novartis, and Roche; and has received an unrestricted grant from Roche for hepatitis research.

Abstract

Answer questions and earn CME

Ancillary